With measles incidence rising globally, this year has already seen the second largest number of domestic cases reported annually since measles was declared eliminated in 2000.
News today that the antibiotic producer Achaogen has filed for bankruptcy represents the most recent consequence of the steep economic challenges facing antibiotic research and development.
Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury. The guideline did not address children and some adult populations, including patients with neutropenia, solid organ transplants, and nonurologic surgery. In the years since the publication of the guideline, further information relevant to ASB has become available. In addition, antimicrobial treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance. The current guideline updates the recommendations of the 2005 guideline, includes new recommendations for populations not previously addressed, and, where relevant, addresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence of ASB.
IDSA Fellowship recognizes individuals who have achieved professional excellence and provided significant service to the profession.Apply Today
Register now for IDWeek 2019 from October 2-6, 2019 in Washington, D.C. Early discounted registration ends June 28!
Clinical Infectious Diseases (CID), one of the most heavily cited journals in the fields of infectious diseases and microbiology, publishes articles on diverse topics in infectious diseases, with a focus on clinical practice.
Founded in 1904, The Journal of Infectious Diseases (JID) is the premier global publication for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms.
Open Forum Infectious Diseases (OFID) provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment.